Sonic Healthcare, an Australian medical laboratory company, acquired Aurora Diagnostics, pathology services and cancer diagnostics company, for $540m. The acquisition of Aurora is expected to be about 3% EPS accretive post-placement on a pro-forma FY2019 basis before expected revenue and cost synergies, Sonic said in a statement. The acquisition will help Sonic substantially grow its operations in the United States.